Naveen S. Vasudev
Beckett Street
Leeds, ENG, United Kingdom
Leeds, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Erratum to "Impact of brain metastases on systemic renal cell carcinoma treatment outcomes: A systematic literature review". [Cancer Treat. Rev. 140 (2025) 103024].
Journal: Cancer treatment reviews
Published: March 04, 2026
Refining Prognosis in Advanced Renal Cell Carcinoma: International Real-World Validation of the Meet-URO Score in First-Line Immunotherapy Combinations.
Journal: The oncologist
Published: December 16, 2025
Refining prognosis in advanced renal cell carcinoma: international real-world validation of the Meet-URO score in first-line immunotherapy combinations.
Journal: The oncologist
Published: December 16, 2025
4-weekly avelumab plus axitinib in patients with metastatic renal cell carcinoma.
Journal: BJC reports
Published: November 19, 2025
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 28, 2025
Impact of brain metastases on systemic renal cell carcinoma treatment outcomes: A systematic literature review.
Journal: Cancer treatment reviews
Published: June 03, 2025
Correction to: Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis.
Journal: Current oncology reports
Published: May 09, 2025
Early Clinical Histotripsy Treatment of Renal Cell Carcinoma.
Journal: Cardiovascular and interventional radiology
Published: March 10, 2025
A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study.
Journal: British journal of cancer
Published: November 04, 2024
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis.
Journal: Current oncology reports
Published: October 05, 2024
Long-read RNA sequencing of archival tissues reveals novel genes and transcripts associated with clear cell renal cell carcinoma recurrence and immune evasion.
Journal: Genome research
Published: December 19, 2023
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 06, 2023
Last Updated: 09/26/2026